Your browser doesn't support javascript.
loading
Comparative effectiveness of BNT162b2 and ChAdOx1 nCoV-19 vaccines against COVID-19.
Wei, Jie; Zhang, Weiya; Doherty, Michael; Wallace, Zachary S; Sparks, Jeffrey A; Lu, Na; Li, Xiaoxiao; Zeng, Chao; Lei, Guanghua; Zhang, Yuqing.
Afiliación
  • Wei J; Health Management Center, Xiangya Hospital, Central South University, Changsha, China.
  • Zhang W; Academic Rheumatology, Clinical Sciences Building, University of Nottingham, City Hospital, Nottingham, UK.
  • Doherty M; Arthritis Research UK Pain Centre, Nottingham, UK.
  • Wallace ZS; Academic Rheumatology, Clinical Sciences Building, University of Nottingham, City Hospital, Nottingham, UK.
  • Sparks JA; Arthritis Research UK Pain Centre, Nottingham, UK.
  • Lu N; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, USA.
  • Li X; The Mongan Institute, Massachusetts General Hospital, Harvard Medical School, Boston, USA.
  • Zeng C; Department of Medicine, Harvard Medical School, Boston, USA.
  • Lei G; Department of Medicine, Harvard Medical School, Boston, USA.
  • Zhang Y; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, USA.
BMC Med ; 21(1): 78, 2023 02 28.
Article en En | MEDLINE | ID: mdl-36855108
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Vacuna BNT162 Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adolescent / Aged / Female / Humans / Male Idioma: En Revista: BMC Med Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Vacuna BNT162 Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adolescent / Aged / Female / Humans / Male Idioma: En Revista: BMC Med Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: China